Evaluation of the Effectiveness of Focused Radiofrequency (TECAR) Therapy on Pain, Disability, Function, and Quality of Life in Patients With Lumbar Disc Herniation

NCT ID: NCT07335718

Last Updated: 2026-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

54 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2026-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Low back pain is a very common health problem in societies, regardless of the underlying cause. Its lifetime prevalence has been reported to be as high as 75-80%. Low back pain negatively affects the quality of life of affected individuals. In addition to diagnostic and treatment costs, it can lead to serious physical disability, resulting in loss of workforce and placing a substantial economic burden on countries. Many different factors play a role in the etiology of low back pain. According to etiology, it can be classified as idiopathic, mechanical, rheumatologic, metabolic, endocrine, infectious, neoplastic, neurologic/psychiatric disorders, and pain of visceral origin. The treatment of low back pain can be classified into medical treatment, physical therapy, percutaneous invasive interventions, and surgical intervention. TECAR therapy is also one of the treatment modalities routinely used in clinical practice. Our aim is to develop more effective physical therapy programs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is planned as a prospective, randomized, double-blind trial. According to power analysis, 54 patients will be included to achieve 95% power. Eligible participants will be women or men aged 20-60 years who are diagnosed with lumbar disc herniation, have low back pain lasting longer than 12 weeks, present to the Ankara Bilkent City Hospital Physical Therapy and Rehabilitation Hospital as outpatients, and consent to participate in the study.

According to the study criteria, initial evaluations will be performed by a single Physical Medicine and Rehabilitation physician. Demographic data of eligible patients, including age, sex, height, weight, occupation, and systemic diseases, will be recorded.

Patients will be evaluated before treatment, immediately after treatment, and one month after the end of treatment using the following scales: Visual Analog Scale (VAS) for pain, Numeric Rating Scale (NRS), Quality of Life Scale (SF-36), Roland-Morris Disability Questionnaire, Oswestry Disability Index, Finger-to-Floor Distance Measurement, Beck Depression Inventory, and Lumbar Schober Test.

Patients will be divided into two groups. The first group will receive a home exercise program including lumbar active range of motion exercises and lumbar isometric strengthening exercises, performed five times per week for three weeks according to the level of movement restriction and pain severity, along with TECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions.

The second group will receive the same home exercise program-including lumbar active range of motion exercises and lumbar isometric strengthening exercises-performed five times per week for three weeks according to the level of movement restriction and pain severity, along with sham TECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Disc Herniation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TECAR Therapy

Patients with lumbar disc herniation

TECAR THERAPY

Intervention Type DEVICE

TECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions

sham TECAR Therapy

Patients with lumbar disc herniation

TECAR Therapy

Intervention Type DEVICE

TECAR therapy is a new and effective treatment modality.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TECAR THERAPY

TECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions

Intervention Type DEVICE

TECAR Therapy

TECAR therapy is a new and effective treatment modality.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having low back pain lasting longer than 12 weeks

Having a diagnosis of lumbar disc herniation (bulging, protruded, or extruded)

Being able to comply with the exercise program

Willingness to participate in the study Being between 20 and 60 years of age

Exclusion Criteria

Being younger than 20 years or older than 60 years

Having a known and/or newly diagnosed malignancy

Presence of cardiac implants such as a pacemaker

Having inflammatory low back pain

Having absolute spinal stenosis (anteroposterior diameter of the spinal canal \< 10 mm and anteroposterior diameter of the lateral recess \< 3 mm)

History of surgery due to lumbar disc herniation, lumbar spinal stenosis, vertebral fracture, or similar conditions

Presence of lumbar spondylolisthesis

Patients with sequestered disc herniation

Patients with polyneuropathy

Patients with central pain following stroke

Patients with neurological deficits

Having a diagnosed neurodegenerative disease

Having a systemic musculoskeletal disease

Patients with acute deep vein thrombosis

Pregnancy

Presence of infection at the skin surface where treatment will be applied

Unexplained weight loss

Bladder and/or bowel incontinence

Having received physical therapy modalities or injections for low back pain within the last 1 month

Having cognitive impairment

Refusal to participate in the study

\-
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara City Hospital Bilkent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cemre Saymaz

DOCTOR

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankara Bilkent City Hospital

Ankara, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

cemre y yılmaz

Role: CONTACT

0312 552 60 00

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

ankara bilkent city hospital ankara bilkent city hospital

Role: primary

0312 552 60 00

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TABED 1-24-833

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.